Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.316
-0.034 (-2.50%)
Nov 5, 2024, 1:03 PM EST - Market open
Kairos Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 17 | - | - | - |
| Enterprise Value | 18 | - | - | - |
| Debt / Equity Ratio | -0.30 | -0.31 | -0.50 | -0.34 |
| Debt / FCF Ratio | 31.32 | 7.93 | -1.66 | -0.96 |
| Quick Ratio | 0.01 | 0.04 | 0.27 | 0.04 |
| Current Ratio | 0.01 | 0.04 | 0.27 | 0.04 |
| Return on Assets (ROA) | -117.65% | -107.07% | -39.41% | - |
| Buyback Yield / Dilution | -1.77% | -1.42% | -11.86% | - |
| Total Shareholder Return | -1.77% | -1.42% | -11.86% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.